The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

Part of paid clinical trials in Chapel Hill, North Carolina.

Sponsor
UNC Lineberger Comprehensive Cancer Center
Study ID
NCT06096623
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Weekly Survey — BEHAVIORAL
    Subjects will respond to Electronic patient-reported outcome (ePRO) every week for 8 weeks.

Study Details

This study assesses the feasibility and acceptability of a brief electronic patient-reported outcome (ePRO) tool that allows patients to self-identify impending delays. The risk of treatment delays according to tumor type and race will be measured by both ePRO and electronic health record (EHR) tools. Data from this study and the association of social determinants of health could be useful to flag patients at risk of delay and due timely intervention for modifiable treatment barriers. The prediction of the risk of treatment delay will be helpful to design another study using electronic tracking systems to prevent cancer treatment delays. The long-term goal of this research is to alert care teams when patients may be at risk of treatment days and to help patients get treatment faster. It was planned to enroll a total of 240 subjects with newly diagnosed cancer. Sixty colorectal and 180 breast cancer patients will be included.

Key Dates

Start date
Nov 6, 2023
Status verified
Jan 2026
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
240 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: electronic patient-reported outcome (ePRO) questionnaires.
    Subjects with colon or breast carcinoma will respond to weekly electronic patient-reported outcome (ePRO) questionnaires.

Primary Outcome Measure

Feasibility of Electronic patient-reported outcome (ePRO) [ Time Frame: Baseline to 56 days post-enrollment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of North CarolinaChapel HillNorth Carolina27599
Erin Laurie-Zehr, MA
[email protected]
919-445-6199
Katie Reeder-Hayes, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chapel Hill, NC

By condition
Breast cancerColorectal cancer
By specialty
OncologyBreast oncologyWomen's healthGI oncology
By research site
University of North Carolina· Chapel Hill, NC

Related Studies